Jain Global LLC Eledon Pharmaceuticals, Inc. Transaction History
Jain Global LLC
- $7.88 Billion
- Q1 2025
A detailed history of Jain Global LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Jain Global LLC holds 67,212 shares of ELDN stock, worth $192,898. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,212Holding current value
$192,898% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
85Shares Held
37.8MCall Options Held
10.5KPut Options Held
66.8K-
Bvf Inc San Francisco, CA6.29MShares$18.1 Million0.94% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$10.2 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$8.48 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$6.68 Million1.01% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.31MShares$6.62 Million2.06% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $39.5M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...